Group One Trading, L.P. Next Cure, Inc. Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.46 - $1.83 $1,235 - $1,548	846 New	846 $1,000
Q3 2022 Nov 09, 2022	BUY	$2.72 - $5.19 $81,852 - $156,182	30,093 New	30,093 $83,000
Q2 2022 Aug 11, 2022	SELL	$3.38 - $5.27 $3,001 - $4,679	-888 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$4.76 - $6.24 $87,417 - $114,597	-18,365 Reduced 95.39%	888 $4,000
Q4 2021 Feb 11, 2022	BUY	$5.7 - $9.1 $109,742 - $175,202	19,253 New	19,253 $116,000
Q1 2021 May 12, 2021	SELL	$9.81 - $13.88 $166,770 - $235,960	-17,000 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$9.47 - $12.43 $160,990 - $211,310	17,000 New	17,000 $185,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $36.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.